Strategic Financial Services, Inc, Pfizer Inc Transaction History

Strategic Financial Services, Inc,

$1.68 Billion
Q3 2024

A detailed history of Strategic Financial Services, Inc, transactions in Pfizer Inc stock. As of the latest transaction made, Strategic Financial Services, Inc, holds 8,673 shares of PFE stock, worth $230,875. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,673

Previous 8,478 2.3%

Holding current value

$230,875

Previous $237,000 5.49%

% of portfolio

0.01%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $5,401 - $6,121	195 Added 2.3%	8,673 $250,000
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $165,377 - $193,791	-6,547 Reduced 43.57%	8,478 $237,000
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $60,401 - $69,360	-2,333 Reduced 13.44%	15,025 $416,000
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $64,750 - $84,103	-2,478 Reduced 12.49%	17,358 $499,000
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $63,955 - $74,757	-1,993 Reduced 9.13%	19,836 $657,000
Q2 2023 Aug 10, 2023	SELL	$36.12 - $41.79 $4,840 - $5,599	-134 Reduced 0.61%	21,829 $800,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $1.06 Million - $1.39 Million	-27,021 Reduced 55.16%	21,963 $896,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $74,273 - $96,955	-1,779 Reduced 3.5%	48,984 $2.51 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $55,531 - $67,789	-1,269 Reduced 2.44%	50,763 $2.22 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $512,155 - $607,256	-11,007 Reduced 17.46%	52,032 $2.73 Million
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $226,233 - $280,332	4,945 Added 8.51%	63,039 $3.26 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $35,700 - $52,920	-864 Reduced 1.47%	58,094 $3.43 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $61,190 - $78,604	-1,559 Reduced 2.58%	58,958 $2.54 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $19,032 - $21,560	-530 Reduced 0.87%	60,517 $2.37 Million
Q1 2021 May 06, 2021	SELL	$33.49 - $37.77 $203,954 - $230,019	-6,090 Reduced 9.07%	61,047 $2.21 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $23,395 - $29,749	-699 Reduced 1.03%	67,137 $2.47 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $67,976 - $79,752	-2,141 Reduced 3.06%	67,836 $2.49 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $844,052 - $1.02 Million	-28,023 Reduced 28.59%	69,977 $2.29 Million
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $385,231 - $550,412	-14,252 Reduced 12.7%	98,000 $3.2 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $758,509 - $860,811	-23,041 Reduced 17.03%	112,252 $4.4 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $90,809 - $117,753	-2,795 Reduced 2.02%	135,293 $4.86 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $69,115 - $77,600	-1,869 Reduced 1.34%	138,088 $5.98 Million
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $63,900 - $70,204	-1,704 Reduced 1.2%	139,957 $5.94 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $482,952 - $550,618	12,554 Added 9.72%	141,661 $6.18 Million
Q3 2018 Oct 25, 2018	SELL	$34.47 - $41.81 $135,639 - $164,522	-3,935 Reduced 2.96%	129,107 $5.69 Million
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $26,219 - $27,952	-795 Reduced 0.59%	133,042 $4.83 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $14,519 - $16,844	455 Added 0.34%	133,837 $4.75 Million
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $9,711 - $10,304	-292 Reduced 0.22%	133,382 $4.83 Million
Q3 2017 Nov 06, 2017	SELL	$31.0 - $34.15 $43,121 - $47,502	-1,391 Reduced 1.03%	133,674 $4.77 Million
Q2 2017 Aug 14, 2017	BUY	N/A	135,065	135,065 $4.54 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Financial Services, Inc,, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Financial Services, Inc, with notifications on news.

Account

Strategic Financial Services, Inc, Pfizer Inc Transaction History